Try our corporate solution for free!
(212) 419-8286

Sanofi pharmaceutical segment revenues by product group 2020

This statistic shows the revenue of Sanofi's pharmaceutical segment by product groups from 2017 to 2019. In 2020, Sanofi's pharmaceutical group generated some 800 million euros of revenue through oncology products. Sanofi is one of the top global pharmaceutical companies. It is headquartered in Paris, France.

Sanofi's segments

Sanofi’s pharmaceutical segment generated 4.7 billion euros in revenue through its diabetes product group in 2020, a decrease compared to nearly 5.5 billion euros in 2018. Lantus is one of Sanofi’s best selling pharmaceutical products. Its revenue has risen from 2.4 billion euros in 2008 to 6.39 billion euros in 2015, but decreased to under three billion in 2020. Lantus is an insulin glargine used daily to control blood sugar levels of patients with diabetes. Clopidogrel, which is marketed under Sanofi’s trade name Plavix, generated 916 million euros in 2020. Plavix is an oral agent that prevents blood clots in patients with some types of heart disease and also prevents heart attacks.

Among its vaccination segment, Sanofi has several profitable products. The company’s influenza vaccines generated some 2.5 billion euros in 2020. Fluzone is a marketed brand of Sanofi’s influenza vaccine, of which varieties exist to target persons of certain age groups.

Sanofi originated in 1973 as a subsidiary of Elf Aquitaine, the company ventured into the U.S. market in 1994. Although, the company is primarily focused on the pharmaceutical market, it also maintains an animal health segment. This segment develops products in four groups including antiparasitics and antiinfectives. Sanofi generated some 36 billion euros in total revenues in 2019. The company expended approximately six billion euros the same year on research and development ventures.

Revenue of Sanofi's pharmaceutical segment by product group in 2020

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until May 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

March 2021



Survey time period


Supplementary notes

* Listed as own product category.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Sanofi"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.